Antigen-specific impairment of adoptive T-cell therapy against cancer: players, mechanisms, solutions and a hypothesis (Q38869740)

7 September 2017

1 reference

title

Antigen-specific impairment of adoptive T-cell therapy against cancer: players, mechanisms, solutions and a hypothesis (English)

1 reference

7 September 2017

1

1 reference

7 September 2017

1 July 2016

1 reference

7 September 2017

Immunological Reviews

1 reference

7 September 2017

272

1 reference

7 September 2017

1

1 reference

7 September 2017

169-182

1 reference

Adoptive immunotherapy for cancer: harnessing the T cell response

7 September 2017

1 reference

Gene-engineered T cells for cancer therapy

21 January 2018

1 reference

Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors.

21 January 2018

1 reference

Adoptive immunotherapy for cancer or viruses

21 January 2018

1 reference

Is cancer gene therapy an empty suit?

21 January 2018

1 reference

T-cell immunotherapy: looking forward

21 January 2018

1 reference

Targeting natural killer cells and natural killer T cells in cancer

21 January 2018

1 reference

Adoptive T Cell Therapy Targeting CD1 and MR1

21 January 2018

1 reference

CD8(+) T cells: foot soldiers of the immune system

21 January 2018

1 reference

The role of the proteasome in the generation of MHC class I ligands and immune responses

21 January 2018

1 reference

Pathways of antigen processing

21 January 2018

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

Neoantigens in cancer immunotherapy.

21 January 2018

1 reference

Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes

21 January 2018

1 reference

Quantifying epitope presentation using mass spectrometry

21 January 2018

1 reference

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

21 January 2018

1 reference

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

21 January 2018

1 reference

Mechanisms of action of therapeutic antibodies for cancer

21 January 2018

1 reference

Adoptive cell transfer as personalized immunotherapy for human cancer

21 January 2018

1 reference

The use of endogenous T cells for adoptive transfer

21 January 2018

1 reference

Prospects for gene-engineered T cell immunotherapy for solid cancers.

21 January 2018

1 reference

Re-adapting T cells for cancer therapy: from mouse models to clinical trials

21 January 2018

1 reference

The basic principles of chimeric antigen receptor design

21 January 2018

1 reference

Design and development of therapies using chimeric antigen receptor-expressing T cells

21 January 2018

1 reference

Engineering T cells for cancer: our synthetic future

21 January 2018

1 reference

Induction of antigen-specific effector-phase tolerance following vaccination against a previously ignored B-cell lymphoma

21 January 2018

1 reference

Target Density, Not Affinity or Avidity of Antigen Recognition, Determines Adoptive T Cell Therapy Outcomes in a Mouse Lymphoma Model.

21 January 2018

1 reference

Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?

21 January 2018

1 reference

T cell receptor antagonist peptides induce positive selection

21 January 2018

1 reference

Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance

21 January 2018

1 reference

Rapid deletion and inactivation of CTLs upon recognition of a number of target cells over a critical threshold.

21 January 2018

1 reference

Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection.

21 January 2018

1 reference

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment

21 January 2018

1 reference

Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity

21 January 2018

1 reference

T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy

21 January 2018

1 reference

Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex

21 January 2018

1 reference

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

21 January 2018

1 reference

High avidity cytotoxic T lymphocytes can be selected into the memory pool but they are exquisitely sensitive to functional impairment

21 January 2018

1 reference

Characterization of two TCR transgenic mouse lines specific for herpes simplex virus.

21 January 2018

1 reference

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

21 January 2018

1 reference

The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture

21 January 2018

1 reference

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

21 January 2018

1 reference

Cross-presentation, dendritic cells, tolerance and immunity

21 January 2018

1 reference

Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells

21 January 2018

1 reference

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

21 January 2018

1 reference

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells

21 January 2018

1 reference

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

B cells directly tolerize CD8(+) T cells

21 January 2018

1 reference

Positive and negative selection of T cells

21 January 2018

1 reference

Peripheral tolerance of CD8 T lymphocytes

21 January 2018

1 reference

How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model

21 January 2018

1 reference

T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity

21 January 2018

1 reference

From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines

21 January 2018

1 reference

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

21 January 2018

1 reference

In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity

21 January 2018

1 reference

Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice

21 January 2018

1 reference

Targeting antigen to diverse APCs inactivates memory CD8+ T cells without eliciting tissue-destructive effector function

21 January 2018

1 reference

Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses

21 January 2018

1 reference

Immune outcomes in the liver: Is CD8 T cell fate determined by the environment?

21 January 2018

1 reference

Harnessing the immune response to treat cancer

21 January 2018

1 reference

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IMR.12433

1 reference

7 September 2017

1 reference

PubMed ID

27319350